Pharmaceutical News

RSS

Pfizer targets five internet sites for selling an unapproved copy of Pfizer's top selling cholesterol medicine, Lipitor

Pfizer has filed lawsuits against the operators of five internet sites for selling an unapproved copy of Pfizer's top selling cholesterol medicine, Lipitor, the company said today.

4 May 2004

First drug product for treatment of short bowel syndrome

Short bowel syndrome (SBS) is a rare and potentially life-threatening condition in which the ability of the small intestine to absorb the nutrition a person needs from food is impaired. Short bowel syndrome can occur after surgical removal of part of the intestine, due to trauma or because the intestine is diseased.

4 May 2004

FDA to create database to help identify counterfeit pharmaceutical brands

The US Food and Drug Administration (FDA) is planning to create a database of the major pharmaceutical brands on the US market, to make it easier to establish the authenticity of suspect products and identify counterfeit versions that enter the supply chain.

3 May 2004

Schering-Plough Corporation settles with $27 million to the State of Texas

Schering-Plough Corporation has announced that it has reached an agreement with the Attorney General's Office of the State of Texas to settle issues related to reimbursement by Texas' Medicaid program of albuterol sulfate solution and inhaler products.

3 May 2004

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Progen Industries Limited, an Australian anti-cancer drug development company, announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for their lead anti-angiogenesis product PI-88 for treatment of malignant melanoma.

3 May 2004

America’s Health Insurance Plans to provide drug discount cards to Medicare beneficiaries

Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), made the following statement regarding HHS Secretary Tommy G. Thompson's announcement today of the start of the prescription drug card program:

3 May 2004

Pharmacy Care Alliance set to begin marketing to Medicare beneficiaries

The Pharmacy Care Alliance today announced that it received approval from Medicare to begin education, outreach and enrollment activities for its Medicare-approved drug discount card on May 3.

3 May 2004

Cymbalta helped patients with depression feel better

Patients treated successfully with 60 mg per day of the investigational antidepressant Cymbalta® (duloxetine hydrochloride), were less likely to have their emotional and physical symptoms of depression return than those who stopped taking medication after beginning to feel better

3 May 2004

Medicare drug discount cards now available

HHS Secretary Tommy G. Thompson announced today that seniors and people with disabilities who receive Medicare can now begin to compare and choose the Medicare-approved drug discount card that best fits their needs in providing savings on their prescription medicines.

3 May 2004

76 percent of Medicare beneficiaries believe the Medicare drug discount cards are a good idea

According to a survey commissioned by the Pharmacy Care Alliance, a large majority-76 percent-of Medicare beneficiaries without prescription drug coverage polled believe the Medicare drug discount cards are a good idea and will help them save money.

2 May 2004

Botox helps children with cerebral palsy

Botox, or botulinum toxin, offers a new, non-surgical option for improving the upper extremity function of children with cerebral palsy (CP), report researchers from Wake Forest University Baptist Medical Center. L. Andrew Koman, M.D., orthopedic surgeon at Brenner Children’s Hospital, and his team recently completed a study using Botox to treat muscle spasticity of the arm and hand in children with CP.

1 May 2004

New medicare website shows inaccurate pricing

The new Medicare Web site with comparative prescription drug pricing contains inaccurate, erroneous information, sponsors of drug discount cards said on Friday. Companies offering the cards said the government and its contractor had posted inaccurate data just hours after the web site launch.

1 May 2004

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

1 May 2004

New UK regulations to better protect patients taking part in clinical trials

New regulations which will better protect the rights, safety and well-being of patients taking part in clinical trials of medicines were welcomed today by Health Minister, Lord Warner.

30 Apr 2004

Agreement supports students seeking health careers

Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.

30 Apr 2004

Changes in the names of medicines, healthcare professionals to be vigilant against medication errors

Healthcare professionals should be aware that alphabetised lists of medicines may have changed and should be careful when selecting medicines to avoid medication errors.

30 Apr 2004

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.

30 Apr 2004

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride decreases and high-density lipoprotein (HDL) cholesterol increases that demonstrated statistically significant improvements from baseline.

30 Apr 2004

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins. In fact, the possibilities of identifying more than 10,000 novel target antigens in the human genome may accelerate the discovery of new drugs and therapeutic molecules.

29 Apr 2004

Cinacalcet drug more successful than a placebo in treating hyperparathyroidism

Research led by Saint Louis University physicians has shown that a new drug can help control one of the most common side effects of kidney disease.

29 Apr 2004

Pharmaceutical News

Pfizer targets five internet sites for selling an unapproved copy of Pfizer's top selling cholesterol medicine, Lipitor

First drug product for treatment of short bowel syndrome

FDA to create database to help identify counterfeit pharmaceutical brands

Schering-Plough Corporation settles with $27 million to the State of Texas

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

America’s Health Insurance Plans to provide drug discount cards to Medicare beneficiaries

Pharmacy Care Alliance set to begin marketing to Medicare beneficiaries

Cymbalta helped patients with depression feel better

Medicare drug discount cards now available

76 percent of Medicare beneficiaries believe the Medicare drug discount cards are a good idea

Botox helps children with cerebral palsy

New medicare website shows inaccurate pricing

FDA approves new drug Enbrel for psoriasis

New UK regulations to better protect patients taking part in clinical trials

Agreement supports students seeking health careers

Changes in the names of medicines, healthcare professionals to be vigilant against medication errors

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Cinacalcet drug more successful than a placebo in treating hyperparathyroidism

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News